Venture backed Domantis acquired
December 8th, 2006 by | No Comments
From Venturewire today: In one of the largest acquisitions ever of a private biotech company, GlaxoSmithKline said this morning it agreed to buy venture-backed Domantis for about $454 million in cash.
Europe’s biggest drug maker said Domantis will become part of GSK’s Biopharmaceuticals Centre of Excellence for Drug Discovery while continuing to operate from laboratories in [...]